During the past decade, CH Ouest Guyanais conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Ouest Guyanais" #1 collaborator was "Centre Hospitalier Universitaire de Pointe-a-Pitre" with 1 trials as a collaborator, "Centre Hospitalier de Cayenne" with 1 trials as a collaborator, "Centre Hospitalier de Monteran, Guadeloupe" with 1 trials as a collaborator, "Centre Hospitalier de Ouest Guyanais Franck Joly" with 1 trials as a collaborator and "Centre d Accueil Psychiatrique Nord, La Réunion" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "CH Ouest Guyanais" are "Sickle Cell Disease" (1 trials) and "Suicide Attempt" (1 trials). Many other conditions were trialed in "CH Ouest Guyanais" in a lesser frequency.

Most popular intervention types in "CH Ouest Guyanais" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "APSOM vs Control" (1 trials) and "Siklos" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Ouest Guyanais" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CH Ouest Guyanais". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CH Ouest Guyanais, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH Ouest Guyanais, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".